1. Home
  2. KLTR vs DTIL Comparison

KLTR vs DTIL Comparison

Compare KLTR & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kaltura Inc.

KLTR

Kaltura Inc.

HOLD

Current Price

$1.30

Market Cap

218.0M

Sector

Technology

ML Signal

HOLD

Logo Precision BioSciences Inc.

DTIL

Precision BioSciences Inc.

HOLD

Current Price

$8.86

Market Cap

185.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KLTR
DTIL
Founded
2006
2006
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
218.0M
185.3M
IPO Year
2021
2019

Fundamental Metrics

Financial Performance
Metric
KLTR
DTIL
Price
$1.30
$8.86
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
2
Target Price
$3.00
$45.00
AVG Volume (30 Days)
338.9K
623.8K
Earning Date
05-08-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
61.90
N/A
EPS
N/A
N/A
Revenue
$180,854,000.00
$1,070,000,000.00
Revenue This Year
$2.96
N/A
Revenue Next Year
$4.96
N/A
P/E Ratio
N/A
N/A
Revenue Growth
1.20
N/A
52 Week Low
$1.06
$3.53
52 Week High
$2.02
$9.62

Technical Indicators

Market Signals
Indicator
KLTR
DTIL
Relative Strength Index (RSI) 45.37 65.96
Support Level $1.22 $6.30
Resistance Level $1.54 $9.62
Average True Range (ATR) 0.05 0.67
MACD 0.00 0.09
Stochastic Oscillator 50.00 75.29

Price Performance

Historical Comparison
KLTR
DTIL

About KLTR Kaltura Inc.

Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and at school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments which are Enterprise, Education, and Technology, and Media and Telecom. The majority of the revenue is derived from Enterprise, Education & Technology. The majority of the revenue is earned from the United States.

About DTIL Precision BioSciences Inc.

Precision BioSciences Inc clinical stage gene editing company utilizing its proprietary ARCUS platform to concurrently develop two clinical-stage in vivo gene editing therapies. The ARCUS platform is used to develop in vivo gene editing therapies for sophisticated gene edits, including gene insertion (inserting DNA into gene to cause expression/add function), elimination (removing a genome, e.g. viral DNA), and excision (removing a large portion of a defective gene by delivering two ARCUS nucleases in a single adeno-associated virus ("AAV")).

Share on Social Networks: